Intco Medical Technology Co., Ltd. (SHE:300677)
China · Delayed Price · Currency is CNY 50.96
+1.78 (3.62%)
Sep 30, 2026, 3:04 PM CST
Intco Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 33,008 | 25,212 | 16,222 | 15,324 | 13,870 | 31,812 | |
Market Cap Growth | 39.61% | 55.42% | 5.86% | 10.48% | -56.40% | -46.22% |
Enterprise Value | 35,744 | 20,990 | 11,386 | 10,593 | 7,078 | 23,841 |
Last Close Price | 50.96 | 38.75 | 25.04 | 23.02 | 20.63 | 46.12 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 29.06 | 24.95 | 11.07 | 40.01 | 22.05 | 4.28 |
Forward PE | 13.50 | 15.83 | 11.93 | 1.46 | 1.46 | 5.01 |
PS Ratio | 2.77 | 2.54 | 1.70 | 2.22 | 2.10 | 1.96 |
PB Ratio | 1.70 | 1.36 | 0.92 | 0.94 | 0.86 | 1.97 |
P/TBV Ratio | 1.80 | 1.44 | 0.98 | 0.99 | 0.91 | 2.09 |
P/FCF Ratio | 33.37 | - | - | - | - | 9.83 |
P/OCF Ratio | 11.39 | 13.38 | 15.03 | 30.50 | 13.02 | 3.67 |
PEG Ratio | - | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.00 | 2.12 | 1.20 | 1.53 | 1.07 | 1.47 |
EV/EBITDA Ratio | 11.07 | 11.21 | 6.46 | 19.02 | 12.71 | 2.66 |
EV/EBIT Ratio | 16.52 | 23.09 | 12.63 | - | - | 2.78 |
EV/FCF Ratio | 36.13 | - | - | - | - | 7.37 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.90 | 0.94 | 0.75 | 0.44 | 0.10 | 0.02 |
Debt / EBITDA Ratio | 5.41 | 9.34 | 7.52 | 12.77 | 2.82 | 0.03 |
Debt / FCF Ratio | 17.67 | - | - | - | - | 0.09 |
Net Debt / Equity Ratio | 0.12 | 0.23 | -0.31 | -0.37 | -0.42 | -0.49 |
Net Debt / EBITDA Ratio | 0.73 | 2.30 | -3.11 | -10.80 | -12.01 | -0.89 |
Net Debt / FCF Ratio | 2.38 | -6.25 | 7.72 | 6.42 | 10.30 | -2.47 |
Asset Turnover | 0.30 | 0.27 | 0.31 | 0.28 | 0.31 | 0.97 |
Inventory Turnover | 4.85 | 5.83 | 6.08 | 5.55 | 5.55 | 6.51 |
Quick Ratio | 0.86 | 0.76 | 1.38 | 1.64 | 2.82 | 4.36 |
Current Ratio | 0.98 | 0.85 | 1.50 | 1.81 | 3.24 | 5.17 |
Return on Equity (ROE) | 6.50% | 5.78% | 8.78% | 2.40% | 3.97% | 58.38% |
Return on Assets (ROA) | 3.35% | 1.52% | 1.83% | -0.42% | -0.21% | 31.97% |
Return on Invested Capital (ROIC) | 7.89% | 4.41% | 7.44% | -1.45% | -0.73% | 129.14% |
Return on Capital Employed (ROCE) | 9.90% | 4.30% | 4.50% | -0.90% | -0.40% | 46.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 3.45% | 4.01% | 9.03% | 2.50% | 4.54% | 23.36% |
FCF Yield | 3.00% | -2.74% | -4.38% | -6.11% | -4.69% | 10.17% |
Dividend Yield | 0.29% | 0.39% | 0.60% | 0.35% | 0.48% | 1.35% |
Payout Ratio | 44.83% | 41.77% | 23.08% | 48.28% | 72.66% | 14.46% |
Buyback Yield / Dilution | -1.44% | 0.72% | 1.80% | 0.28% | 1.97% | -9.01% |
Total Shareholder Return | -1.14% | 1.11% | 2.40% | 0.63% | 2.44% | -7.65% |